KLF4 and cancer: Previously, we demonstrated that transgenic overexpression of Klf4 within esophageal keratinocytes activates NFκB signaling, which is associated with the development numerous inflammatory diseases and cancers [11–20], resulting in inflammation-mediated ESCC [7].